Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (2): 156-161.doi: 10.3969/j.issn.1000-6621.2019.02.007
• Original Articles • Previous Articles Next Articles
Zhi-hua CAO(),Yue-zhu ZHAO,Shuang-shuang HU
Received:
2018-11-19
Online:
2019-02-10
Published:
2019-02-01
Contact:
Zhi-hua CAO
E-mail:3035660368@qq.com
Zhi-hua CAO,Yue-zhu ZHAO,Shuang-shuang HU. Detection of drug resistance mutations in Mycobacterium tuberculosis to five antitubercular drugs using the fluorescent PCR probe melting curve method[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 156-161. doi: 10.3969/j.issn.1000-6621.2019.02.007
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.02.007
[1] |
Zumla A, George A, Sharma V , et al. The WHO 2014 Global tuberculosis report—further to go. Lancet Glob Health, 2015,3(1):e10-12.
doi: 10.1016/S2214-109X(14)70361-4 URL |
[2] |
Gandhi NR, Nunn P, Dheda K , et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet, 2010,375(9728):1830-1843.
doi: 10.1016/S0140-6736(10)60410-2 URL |
[3] |
Zignol M, Hosseini MS, Wright A , et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis, 2006,194(8):479-485.
doi: 10.1086/jid.2006.194.issue-4 URL |
[4] | Caminero JA . Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis, 2010,14(4):382-390. |
[5] |
Cox H, Hughes J, Black J , et al. Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible. Lancet Infect Dis, 2018,18(9):e282-e287
doi: 10.1016/S1473-3099(18)30104-X URL |
[6] | 谭家莉 . 耐药结核病的防治现状及有效对策. 医药前沿, 2014(36):56-56. |
[7] | 沈欣, 宋沈超, 雷世光 . 耐药结核病流行现状及防控对策. 职业与健康, 2017,33(4):566-568. |
[8] | 杜娟 . 严重耐多药结核病的流行现状、防控难点及对策. 医学研究杂志, 2010,39(8):17-21. |
[9] |
Zhang Z, Wang Y, Pang Y , et al. Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2014,58(9):5632-5635.
doi: 10.1128/AAC.02778-14 URL |
[10] | 武洁, 桂晓虹, 李静 , 等. 比例法与绝对浓度法检测结核分枝杆菌药敏试验的比较. 中华检验医学杂志, 2011,34(2):137-138. |
[11] | Palomino JC . Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol, 2013,56(2):103-111. |
[12] |
Ioannidis P, Papaventsis D, Karabela S , et al. Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J Clin Microbiol, 2011,49(8):3068-3070.
doi: 10.1128/JCM.00718-11 URL |
[13] | 张明霞, 代友超 . 耐多药结核病检测技术研究进展. 中国热带医学, 2017,17(3):312-316. |
[14] | 徐费凡, 顾德林, 瞿梅 , 等. 荧光PCR溶解曲线法快速检测结核分枝杆菌对利福平和异烟肼的耐药突变. 热带医学杂志, 2016,16(6):722-724. |
[15] | 刘靖元, 李仁龙, 徐亚军 . 应用单链探针反向杂交试验检测结核分枝杆菌耐药性分析. 中国医药科学, 2012,2(13):26-28. |
[16] | 姚春艳, 张立群, 府伟灵 . 应用基因芯片技术检测结核分枝杆菌耐药基因. 中华医院感染学杂志, 2010,20(11):1501-1504. |
[17] | 李兰, 郭述良, 罗永艾 . 结核病发病机制的研究进展. 中华结核和呼吸杂志, 2009,32(8):620-622. |
[18] | 中国防痨协会基础专业委员会. 结核病诊断实验室检验规程.北京: 中国教育文化出版社, 2006. |
[19] | Antonova AV, Gryadunov DA, Zimenkov DV . Molecular mechanisms of drug tolerance in Mycobacterium tuberculosis. Mol Biol (Mosk), 2018,52(3):435-450. |
[20] |
Trauner A, Liu Q, Via LE , et al. The within-host population dynamics of Mycobacterium tuberculosis, vary with treatment efficacy. Genome Biol, 2017,18(1):71.
doi: 10.1186/s13059-017-1196-0 URL |
[21] | World Health Organization . Global tuberculosis report 2017. Geneva:World Heallth Organization, 2017. |
[22] |
Lempens P, Meehan CJ, Vandelannoote K , et al. Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations. Sci Rep, 2018,8(1):3246.
doi: 10.1038/s41598-018-21378-x URL |
[23] |
McGrath M, Gey van Pittius NC, van Helden PD , et al. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother, 2014,69(2):292-302.
doi: 10.1093/jac/dkt364 URL |
[24] |
Fenner L, Egger M, Bodmer T , et al. Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2012,56(6):3047-3053.
doi: 10.1128/AAC.06460-11 URL |
[25] | Al-mutairi NM, Ahmad S, Mokaddas E . Performance compari-son of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains. Int J Tuberc Lung Dis, 2011,15(1):110-115. |
[26] | Moon HW, Hur M, Kim JY , et al. Comparison of three molecular assays for the detection of Rifampin resistance in Mycobacterium tuberculosis. J Clin Lab Anal, 2015,53(9):3032-3034. |
[27] | 张太松, 李明 . 分子诊断技术在耐多药结核分枝杆菌检测中的应用进展. 分子诊断与治疗杂志, 2009,1(2):129-134. |
[28] |
Elenitoba-Johnson KSJ, Bohling SD, Wittwer CT , et al. Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis. Nat Med, 2001,7(2):249-253.
doi: 10.1038/84708 URL |
[29] | 马艳艳, 李辉, 赵东阳 , 等. 荧光PCR探针熔解曲线法检测结核分枝杆菌耐利福平突变研究. 中国国境卫生检疫杂志, 2011,34(6):451-454. |
[30] | 严虹, 施旭东, 胡春梅 , 等. 探针熔解曲线法快速检测结核分枝杆菌利福平、异烟肼、乙胺丁醇及链霉素耐药突变. 临床检验杂志, 2015,33(10):729-733. |
[31] | 李国利, 李庆阁, 王倩 , 等. PCR-探针熔解分析法检测结核分枝杆菌氟喹诺酮耐药基因突变的临床应用评价. 中华临床医师杂志(电子版), 2011,5(16):4641-4645. |
[1] | Yan Guangxuan, Wang Xueyu, Wang Yujin, Lan Tinglong, Nie Wenjuan. Diagnostic value of using metagenomic second-generation sequencing on suspected osteoarticular tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 175-180. |
[2] | Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei. Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60. |
[3] | Chen Shuangshuang, Tian Lili, Wang Nenhan, Yang Xinyu, Zhao Yanfeng, Li Chuanyou, Dai Xiaowei. Analysis of in vitro antibacterial effects of 17 antibiotics against rapidly growing mycobacteria in the Beijing area [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1056-1062. |
[4] | Wang Biao, Liu Yuhong, Sun Yuxian, Zhang Lijie, Li Zhili, Shu Wei. Investigation and analysis of laboratory diagnostic capabilities in tuberculosis-designated hospitals in China [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1089-1097. |
[5] | Xue Yi, Liang Qian, Qi Haoran, Liang Ruixia, Huang Hairong. Reliability analysis of rifampicin-resistance detected by different diagnostics as a predictor for multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 892-896. |
[6] | Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei. Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950. |
[7] | Jia Hongyan, Fan Jun, Sun Qi, Song Ruixue, Du Boping, Dong Jing, Wang Yingchao, Xing Aiying, Zhu Chuanzhi, Li Zihui, Pan Liping. Comparison of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold In-Tube assay in auxiliary diagnosis of osteoarticular tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 648-653. |
[8] | Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin. Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423. |
[9] | Cheng Mengli, Jiang Guanglu, Huo Fengmin, Xue Yi, Yu Xia. Evaluation of in vitro activity of fusidic acid against mycobacteria [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 461-466. |
[10] | Pei Shaojun, Ou Xichao. Interpretation of the World Health Organization’s Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance (2nd Edition) [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 260-266. |
[11] | Li Ting, Liu Shuang, Wang Danxia, Lu Jia, Cheng Qianqian, Chen Chuang, He Jin’ge, Zhang Linglin, Xia Yong, Li Jing, Zhang Shu, Gao Wenfeng, Xia Lan. Evaluation of health economics of implementation of tuberculosis prevention and control program in Sichuan Province from 2011 to 2020 [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 333-339. |
[12] | Li Xuelian, Jing Wei, Wang Qingfeng, Chu Naihui, Nie Wenjuan. An all-oral shortened regimen containing new drugs to treat MDR/rifampicin-resistant tuberculosis: three case reports and literature review [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1327-1334. |
[13] | Hu Qiang, Jin Linyuan, Zhou Xiaohui, Zhang Qianrong, Deng Yuhang, Tang Xianpeng, Zhou Haiyi, Zhang Min. The value of ultrasound examination in the diagnosis and treatment evaluation of chest tuberculosis in children [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1350-1355. |
[14] | Li Jing, Jiang Qi, Jiang Yuan, Shen Xin. Evaluation of performance of PCR fluorescent probe method for detecting Mycobacterium tuberculosis complex and rifampicin resistance [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1250-1258. |
[15] | Song Hongge, Liu Weigao. Evaluation of the curative effect of total hip joint type space holder in the treatment of middle and advanced hip joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(8): 781-785. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||